Rastenil en es it fr

Rastenil Brand names, Rastenil Analogs

Rastenil Brand Names Mixture

  • No information avaliable

Rastenil Chemical_Formula


Rastenil RX_link

No information avaliable

Rastenil fda sheet

Rastenil msds (material safety sheet)

Rastenil Synthesis Reference

No information avaliable

Rastenil Molecular Weight

309.469 g/mol

Rastenil Melting Point

< 25 oC

Rastenil H2O Solubility

Soluble as HCl salt

Rastenil State


Rastenil LogP


Rastenil Dosage Forms

Tablets (oral, 1 mg)

Rastenil Indication

Used for the symptomatic treatment of parkinsonism.

Rastenil Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Rastenil Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Rastenil side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Rastenil Patient Information

Rastenil Organisms Affected

Humans and other mammals